A 52-year-old man with Stage 4 CKD (eGFR 18 mL/min/1.73m²) secondary to diabetic nephropathy presents with fatigue and dyspnea on exertion. Hemoglobin is 8.2 g/dL, MCV 82 fL, reticulocyte count 0.8%. Serum creatinine 3.8 mg/dL, BUN 58 mg/dL. Iron studies show serum iron 45 µg/dL, ferritin 280 ng/mL, TIBC 240 µg/dL. Peripheral blood smear shows normocytic red cells. What is the PRIMARY mechanism of anemia in this patient?

Explanation

## Pathophysiology of CKD-Related Anemia **Key Point:** Anemia of chronic kidney disease is primarily due to **relative erythropoietin (EPO) deficiency**, not absolute iron deficiency or hemolysis. ### Mechanism in This Case The kidneys produce ~90% of circulating EPO. In advanced CKD, the failing renal parenchyma loses this capacity, resulting in inadequate EPO response to anemia. The patient's: - **Normocytic, normochromic picture** (MCV 82, normal range) — rules out iron deficiency (microcytic) or B12 deficiency (macrocytic) - **Low reticulocyte count (0.8%)** — demonstrates inadequate bone marrow response, consistent with EPO deficiency rather than hemolysis (which would show elevated retics) - **Adequate iron stores** (ferritin 280 ng/mL, normal TIBC ratio) — iron is not the limiting factor ### Contributing Factors in CKD Anemia | Factor | Mechanism | Relative Importance | |--------|-----------|--------------------| | **EPO deficiency** | Loss of renal EPO production | Primary (70–80%) | | **Uremic inhibitors** | Accumulation of uremic toxins suppressing erythropoiesis | Secondary | | **Shortened RBC lifespan** | Uremic environment damages RBC membrane | Minor | | **Blood loss** | Dialysis, occult GI bleeding | Minor in non-dialysis CKD | | **Iron deficiency** | Occurs ONLY if dialysis losses or GI bleeding present | Not present here | **Clinical Pearl:** The normocytic anemia with low reticulocyte count in the setting of advanced CKD is pathognomonic for EPO deficiency. Iron studies are normal here, so iron supplementation alone would not correct the anemia. **High-Yield:** CKD anemia becomes clinically significant at eGFR <45 mL/min and worsens as eGFR falls below 20. EPO-stimulating agents (ESAs) are the standard of care, with iron supplementation reserved for documented iron deficiency [cite:KDIGO 2012 Anemia Guidelines]. ### Why Reticulocyte Count Matters A **low reticulocyte count in the face of anemia** indicates the bone marrow is not responding appropriately — the hallmark of EPO deficiency. In hemolysis, retics would be elevated (>2–3%).